2019
DOI: 10.1097/01.hs9.0000565324.90331.15
|View full text |Cite
|
Sign up to set email alerts
|

Pb1702 Expression of Angiotensin‐converting Enzyme in Patients With Acute Leukemias

Abstract: Azacytidine and/or decitabine (DAC) were dramatically improved the prognosis of MDS and AML. Whereas, these drugs can be administered intravenously or subcutaneously, therefore the patients must visit a hospital every day. Aims: OR21 is a novel and potentially oral absorbable DAC prodrug. Actually, direct duodenal administration of OR21 successfully absorbed in cynomolgus monkey model. In this study, we investigated the efficacy of OR21 in MDS (MDS-L), AML cell lines (HL60, THP1, KG1a, Kasumi-1). Methods: OR21… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles